Nvidia Invests $2B in CoreWeave, OpenAI Ramps Up Enterprise Push
The Rundown
00:00
Revolution Medicines Deal Collapses
Zaid covers Merck walking away from acquisition talks and investor concerns ahead of upcoming trial data for Revolution.
Play episode from 06:56
Transcript
